Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1121-1130 of 2286 for

Edit search filters
  1. Combination Therapies with Adagrasib in Patients with Advanced NSCLC With KRAS G12C Mutation

    Jacksonville, FL, Rochester, MN

  2. Genetic Testing With Family History Of Pancreatic Cancer

    Jacksonville, FL

  3. Synergy with Grid Therapy and Immune Checkpoint Inhibitors in Stage IV Non-Small Cell Lung Cancer

    Rochester, MN

  4. Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. PSMA PET For Metastatic Adenoid Cystic Carcinoma (ACC)

    Rochester, MN

  6. Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study to Investigate LYL845 in Adults With Solid Tumors

    Rochester, MN

  8. BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants (PATAPSCO)

    Scottsdale/Phoenix, AZ

  9. Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

    Scottsdale/Phoenix, AZ

  10. A Phase 3 Study To Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy In Previously Treated Head And Neck Squamous Cell Carcinoma Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer